Feline Portosystemic Shunt: Diagnosis and Management

Congenital portosystemic shunt (PSS) in cats is a vascular anomaly that allows portal blood to bypass the liver, leading to hepatic encephalopathy, poor growth, and urinary tract signs. This article provides veterinary clinicians with a practical framework for diagnosing and managing feline PSS, covering pathophysiology, clinical presentation, diagnostic testing, medical stabilization, and surgical attenuation options. The content is based on peer-reviewed literature and official veterinary guidelines, with emphasis on concrete decision-making steps and escalation criteria.

At a Glance

Pathophysiology and Classification

Congenital portosystemic shunts in cats result from abnormal vascular development during embryogenesis, allowing portal blood to bypass the hepatic sinusoids and enter the systemic circulation directly. This shunting deprives the liver of hepatotrophic factors and exposes the systemic circulation to toxins that would normally be metabolized by the liver. The most clinically significant toxin is ammonia, which contributes to hepatic encephalopathy.

Shunt Types

Shunts are classified anatomically as intrahepatic or extrahepatic. Extrahepatic shunts are more common in cats, typically connecting the portal vein or its tributaries to the caudal vena cava or azygos vein. Intrahepatic shunts, though less frequent, involve a patent ductus venosus or other anomalous connections within the liver parenchyma. The classification influences surgical approach and prognosis, as described in the review "Congenital Portosystemic Shunts in Dogs and Cats: Classification, Pathophysiology, Clinical Presentation and Diagnosis" (Veterinary sciences, 2023, PubMed ID 36851464).

Hepatic Encephalopathy

Hepatic encephalopathy (HE) results from the accumulation of neurotoxic substances, particularly ammonia, but also including mercaptans, short-chain fatty acids, and aromatic amino acids. These substances alter neurotransmitter function, increase cerebral edema, and impair energy metabolism. The clinical signs of HE are often intermittent and may be triggered by high-protein meals, gastrointestinal bleeding, constipation, or concurrent illness. Understanding this pathophysiology guides both diagnostic testing and medical management.

Clinical Presentation

The clinical signs of feline PSS are variable and often nonspecific, which can delay diagnosis. A thorough history and physical examination are essential, particularly in young cats with unexplained neurologic or gastrointestinal signs.

Signalment and History

Most cats with congenital PSS present before two years of age, though some may not show signs until later. Purebred cats, including Persians, Himalayans, and Siamese, appear to be overrepresented. Owners may report a history of poor growth, intermittent lethargy, vomiting, diarrhea, or ptyalism. Neurologic signs such as circling, head pressing, aimless wandering, or seizures are common and may be mistaken for primary epilepsy or toxicosis.

Physical Examination Findings

Physical examination may reveal a small, unthrifty cat with poor body condition. Neurologic examination can show dull mentation, ataxia, or abnormal behavior. Some cats have a palpable abdominal fluid wave from ascites, though this is less common than in dogs. Copper-colored irises have been reported in some cats with PSS, but this finding is not consistent. A thorough examination should also assess for other congenital anomalies, as PSS can occur with other defects.

Common Failure Patterns in Diagnosis

A common diagnostic failure is attributing neurologic signs to idiopathic epilepsy or toxin exposure without considering PSS. Another pattern is misinterpreting intermittent signs as behavioral issues. Clinicians should maintain a high index of suspicion for PSS in any young cat with recurrent neurologic signs, especially if signs are triggered by eating. Failure to perform bile acid testing before anticonvulsant therapy can delay diagnosis and appropriate management.

Diagnostic Testing

Confirming a diagnosis of PSS requires a combination of laboratory tests and imaging. The goal is to demonstrate portosystemic shunting and identify the shunt anatomy for surgical planning.

Serum Bile Acids

Fasting and postprandial serum bile acids are the most commonly used screening tests for PSS. Bile acids are normally extracted from portal blood by the liver, elevated levels indicate shunting. The test involves collecting a fasting sample, feeding a small meal, and collecting a second sample two hours later. Elevated postprandial bile acids are more sensitive than fasting levels alone. However, bile acids can be elevated in other liver diseases, so results must be interpreted in context. The Merck Veterinary Manual provides guidance on interpreting bile acid results in cats (Merck Veterinary Manual, www.merckvetmanual.com/).

Serum Ammonia

Serum ammonia is another useful test, as ammonia is a direct neurotoxin that accumulates in PSS. Ammonia levels are often markedly elevated in cats with PSS, though they can be normal in some cases. Sample handling is critical: blood must be collected in a heparinized tube, placed on ice, and processed within 30 minutes. False elevations can occur with hemolysis or delayed processing. Ammonia tolerance testing (measuring ammonia before and after an oral ammonia challenge) can increase sensitivity but is rarely performed in practice.

Complete Blood Count and Biochemistry

Routine hematology and biochemistry may reveal supportive abnormalities. Microcytosis is common in cats with PSS due to altered iron metabolism. Liver enzymes may be normal or mildly elevated. Hypoalbuminemia, low blood urea nitrogen (BUN), and low cholesterol are frequent findings due to reduced hepatic synthetic function. A retrospective study of biochemical profile changes in cats with hepatobiliary diseases (Journal of feline medicine and surgery, 2025, PubMed ID 40470580) provides context for interpreting these abnormalities.

Urinalysis

Urinalysis may reveal ammonium biurate crystals or struvite crystalluria. Cats with PSS are predisposed to urate urolithiasis because uric acid is not adequately converted to allantoin in the liver. Urine specific gravity may be low due to reduced renal concentrating ability. A complete urinalysis should be part of the initial diagnostic workup.

Abdominal Ultrasound

Ultrasound is the most accessible imaging modality for PSS. An experienced ultrasonographer can identify the anomalous vessel, assess liver size, and evaluate for concurrent abnormalities such as microhepatica or ascites. The sensitivity of ultrasound for detecting PSS varies with operator experience and shunt location. A study on ultrasonographic diagnosis of portosystemic shunting in dogs and cats (Veterinary radiology & ultrasound, 2004, PubMed ID 15487568) describes the technique and limitations. Extrahepatic shunts are generally easier to identify than intrahepatic shunts.

Computed Tomography Angiography

CT angiography is the gold standard for characterizing shunt anatomy. It provides detailed three-dimensional images of the portal vasculature, allowing precise identification of shunt origin, insertion, and number. This information is critical for surgical planning, particularly for intrahepatic shunts. CT angiography requires general anesthesia and specialized equipment but offers superior diagnostic accuracy compared to ultrasound alone.

Practical Diagnostic Workflow

A practical approach begins with screening bile acids in any young cat with compatible clinical signs. If bile acids are elevated, proceed to abdominal ultrasound to identify the shunt. If ultrasound is inconclusive or surgical planning requires detailed anatomy, perform CT angiography. Serum ammonia can be used as a confirmatory test or when bile acid testing is unavailable. This stepwise approach minimizes unnecessary testing while ensuring accurate diagnosis.

Medical Management

Medical management aims to reduce ammonia production and absorption, control clinical signs, and stabilize the patient for surgery. It is also used as long-term therapy when surgical attenuation is not possible or declined.

Dietary Modification

A low-protein, high-quality diet is the cornerstone of medical management. Protein restriction reduces the substrate for ammonia production by intestinal bacteria. Commercial hepatic support diets are available and are formulated to provide adequate nutrition while minimizing protein load. In cats, protein restriction must be balanced against the risk of malnutrition, as cats are obligate carnivores. Gradual dietary transition is recommended to avoid anorexia.

Lactulose

Lactulose is a non-absorbable disaccharide that acidifies the colon, trapping ammonia as ammonium ions and promoting its excretion in feces. It also has a laxative effect, reducing intestinal transit time and bacterial fermentation. The typical dose is 0.5 to 1 mL per kilogram orally every 8 to 12 hours, titrated to produce 2 to 3 soft stools per day. Overdose can cause diarrhea and dehydration. Lactulose is generally well tolerated but may cause flatulence and abdominal discomfort.

Antibiotics

Oral antibiotics reduce the population of urease-producing bacteria in the colon, decreasing ammonia production. Neomycin and metronidazole are commonly used. Neomycin is a non-absorbable aminoglycoside that acts locally in the gut. Metronidazole has both antibacterial and anti-inflammatory effects. Antibiotics are typically used short-term for acute hepatic encephalopathy or as adjunctive therapy in refractory cases. Long-term antibiotic use carries risks of dysbiosis and antimicrobial resistance. The diagnosis and interpretation of intestinal dysbiosis in dogs and cats (Veterinary Journal, 2016, Elsevier Scopus ID 10.1016/j.tvjl.2016.04.011) provides context for understanding these risks.

Anticonvulsants

Cats with seizures due to hepatic encephalopathy may require anticonvulsant therapy. Levetiracetam is often preferred because it has minimal hepatic metabolism and few drug interactions. Phenobarbital can be used but requires careful monitoring due to hepatic metabolism. Seizure control is an important goal, as repeated seizures can worsen neurologic status. Anticonvulsant therapy should be combined with dietary and medical management of the underlying PSS.

Fluid Therapy and Supportive Care

Cats with acute hepatic encephalopathy may require intravenous fluid therapy for hydration and to correct electrolyte imbalances. Lactated Ringer's solution is generally safe, though some clinicians prefer a balanced electrolyte solution. Dextrose supplementation may be needed if hypoglycemia is present. Enemas can be used to evacuate the colon and reduce ammonia absorption in severe cases. Close monitoring of mentation, hydration, and electrolyte status is essential.

Professional Escalation Criteria

Medical management should be escalated to surgical consultation if clinical signs persist despite optimal medical therapy, if the cat experiences recurrent episodes of hepatic encephalopathy, or if quality of life is compromised. Cats with intrahepatic shunts or complex shunt anatomy may require referral to a specialty center with advanced imaging and surgical capabilities. Any cat with seizures, coma, or severe neurologic signs should be hospitalized for intensive care and urgent surgical evaluation.

Surgical Attenuation

Surgical attenuation is the treatment for congenital PSS in cats. The goal is to gradually or completely occlude the shunt vessel, redirecting portal blood flow through the liver. Several techniques are available, each with advantages and limitations.

Preoperative Stabilization

Before surgery, cats should be medically stabilized to reduce the risk of complications. This includes dietary modification, lactulose, and antibiotics as needed. Neurologic signs should be controlled, and hydration and electrolyte status should be normal. Preoperative bile acids or ammonia levels can be used to assess response to medical therapy. Anesthesia planning should account for reduced hepatic function and potential for hypoglycemia.

Cellophane Banding

Cellophane banding involves placing a sterile cellophane band around the shunt vessel. The band induces a foreign body reaction and progressive fibrosis, leading to gradual occlusion over 4 to 8 weeks. This technique allows slow attenuation, reducing the risk of acute portal hypertension. Cellophane banding is relatively simple to perform and does not require specialized equipment. However, the degree of occlusion is not immediately controllable, and some shunts may not close completely.

Ameroid Constrictor

The ameroid constrictor is a ring-shaped device with a hygroscopic casein core that swells over time, gradually occluding the shunt. The device is placed around the shunt vessel and provides predictable, progressive occlusion over 2 to 4 weeks. Ameroid constrictors are widely used and have good success rates in cats. The main limitation is the cost of the device and the need for precise sizing. The review "Congenital Portosystemic Shunts in Dogs and Cats: Treatment, Complications and Prognosis" (Veterinary sciences, 2023, PubMed ID 37235429) discusses outcomes with various attenuation techniques.

Suture Ligation

Suture ligation involves placing a non-absorbable suture around the shunt and tightening it to achieve partial or complete occlusion. This technique allows immediate control of shunt flow but carries a higher risk of acute portal hypertension if occlusion is too aggressive. Suture ligation is typically reserved for extrahepatic shunts that are easily accessible. Intraoperative portal pressure monitoring is essential to guide the degree of occlusion.

Intrahepatic Shunt Management

Intrahepatic shunts are more challenging to manage surgically. Options include cellophane banding, ameroid constrictor placement, or more advanced techniques such as thrombogenic coil embolization or stent placement. These procedures require specialized equipment and expertise and are typically performed at referral centers. The article "Intrahepatic Congenital Portosystemic Shunts" (The Veterinary clinics of North America. Small animal practice, 2025, PubMed ID 40274472) provides detailed guidance on managing these complex cases.

Postoperative Monitoring

After surgery, cats require close monitoring for complications. Portal hypertension is the most serious early complication, manifesting as abdominal pain, vomiting, diarrhea, or ascites. Signs of portal hypertension should prompt immediate intervention, including fluid resuscitation and possible surgical revision. Other complications include hypoglycemia, seizures, and pancreatitis. Most cats can be discharged within 2 to 4 days if recovery is uneventful.

Long-Term Outcome

The prognosis for cats undergoing successful shunt attenuation is good to excellent. Most cats achieve normal growth, resolution of neurologic signs, and improved quality of life. Long-term dietary modification may not be necessary after complete shunt closure. However, some cats may have persistent mild bile acid elevations or require continued medical management. Regular follow-up with bile acid testing and clinical assessment is recommended.

Records and Measurements

Accurate record-keeping is essential for managing feline PSS cases. The following measurements and observations should be documented at each visit.

Baseline Data

Record signalment, presenting signs, and duration of clinical signs. Document any triggering factors such as dietary indiscretion or stress. Note body weight, body condition score, and growth trajectory in young cats. Baseline laboratory values including bile acids, ammonia, CBC, biochemistry, and urinalysis should be recorded.

Treatment Response

For cats on medical management, document the dose and frequency of lactulose and antibiotics. Record stool frequency and consistency, as this guides lactulose titration. Note any changes in neurologic status, appetite, and activity level. Serial bile acids or ammonia levels can be used to assess response to therapy.

Surgical Records

For surgical cases, document the shunt type, location, and attenuation technique used. Record intraoperative portal pressures if measured. Note any complications during surgery or recovery. Postoperative monitoring should include daily body weight, hydration status, and neurologic assessment. Follow-up bile acids should be measured at 1, 3, and 6 months postoperatively, then annually.

Common Failure Patterns in Record Keeping

A common failure is not documenting baseline bile acids before starting medical therapy, making it difficult to assess treatment response. Another pattern is inconsistent recording of lactulose dosing and stool output, leading to suboptimal titration. Failure to schedule regular follow-up appointments can result in missed complications or incomplete shunt closure. Clinicians should establish a standardized record-keeping protocol for PSS cases.

Welfare and Safety Context

Managing feline PSS involves important welfare considerations. Hepatic encephalopathy can cause significant suffering, including seizures, disorientation, and pain. Prompt diagnosis and treatment are essential to minimize distress. Surgical attenuation, while curative, carries risks of complications that must be discussed with owners.

Quality of Life Assessment

Quality of life should be assessed regularly, particularly for cats managed medically. Owners should be asked about the cat's appetite, activity level, interaction with family, and frequency of neurologic episodes. A decline in quality of life may indicate the need for surgical intervention or adjustment of medical therapy. The World Organisation for Animal Health provides general guidance on animal welfare assessment (Animal Health and Welfare, WOAH, www.woah.org/en/what-we-do/animal-health-and-welfare).

Owner Communication

Clear communication with owners is critical. Explain the nature of the condition, treatment options, and expected outcomes. Discuss the risks and benefits of surgery versus medical management. Provide written instructions for medication administration, dietary management, and monitoring for complications. Set realistic expectations for recovery time and long-term prognosis.

Professional Escalation Criteria

Clinicians should refer cases to a specialist if they lack experience with PSS surgery, if the shunt is intrahepatic or complex, or if complications arise during medical management. Any cat with refractory seizures, progressive neurologic decline, or signs of portal hypertension after surgery should be referred immediately. Collaboration with a veterinary internist or surgeon improves outcomes for complex cases.

Limitations and Considerations

Several limitations affect the diagnosis and management of feline PSS. Understanding these helps clinicians make informed decisions and avoid common pitfalls.

Diagnostic Limitations

Bile acid testing has limitations in cats. Some cats with PSS may have normal bile acids, particularly if the shunt is small or if the cat is on medical therapy. Conversely, bile acids can be elevated in other liver diseases, leading to false positives. Ultrasound is operator-dependent and may miss small or atypically located shunts. CT angiography, while accurate, requires anesthesia and is not available in all practices.

Medical Management Limitations

Medical management does not correct the underlying shunt and is palliative. Cats may require lifelong therapy, and clinical signs can recur with dietary indiscretion or intercurrent illness. Long-term antibiotic use carries risks of dysbiosis and antimicrobial resistance. Lactulose can cause diarrhea and electrolyte imbalances if not carefully titrated. The cost and availability of hepatic support diets may be a barrier for some owners.

Surgical Limitations

Surgical attenuation is not always possible. Some shunts are inaccessible or too large to attenuate safely. Intrahepatic shunts require advanced surgical techniques and equipment. Complications such as portal hypertension, seizures, or pancreatitis can occur even with careful technique. Not all cats achieve complete shunt closure, and some may require continued medical management.

Prognostic Limitations

While most cats do well after successful surgery, some may have persistent neurologic deficits or require long-term medication. The long-term prognosis for cats with intrahepatic shunts or those managed medically is more guarded. Owners should be counseled about the possibility of incomplete resolution of signs.

Practical Decision Framework for Feline Portosystemic Shunt Management

A structured decision framework helps clinicians navigate the diagnostic and therapeutic choices for feline portosystemic shunt cases. This section provides a stepwise approach for case triage, treatment selection, and monitoring, with specific criteria for escalation and troubleshooting. The framework is based on peer-reviewed literature and official veterinary guidelines, including the Merck Veterinary Manual (www.merckvetmanual.com/) and the American College of Veterinary Internal Medicine resources (www.acvim.org/).

Case Triage and Initial Decision Points

The first decision point occurs when a young cat presents with compatible clinical signs. The clinician must determine the likelihood of PSS and the urgency of diagnostic testing. Cats with acute neurologic signs such as seizures or coma require immediate stabilization and diagnostic workup. Cats with intermittent or mild signs can undergo scheduled testing.

Urgency Assessment Criteria

Use the following criteria to determine urgency:

• Emergency presentation: Active seizures, coma, severe ataxia, or inability to stand. These cats require immediate hospitalization, intravenous fluid therapy, and diagnostic testing within hours.
• Urgent presentation: Intermittent neurologic signs, recurrent vomiting, or poor growth. These cats should be evaluated within 24 to 48 hours.
• Routine presentation: Mild behavioral changes, occasional ptyalism, or incidental laboratory abnormalities. These cats can be scheduled for diagnostic testing within one week.

Document the urgency level in the medical record and communicate it clearly to the owner. Failure to recognize an emergency presentation can lead to delayed treatment and worsening of hepatic encephalopathy.

Diagnostic Pathway Selection

Once the decision to test is made, select the diagnostic pathway based on available resources and clinical suspicion:

• Pathway A (high suspicion, ultrasound available): Perform fasting and postprandial bile acids and abdominal ultrasound on the same day. This pathway provides rapid confirmation and anatomic information.
• Pathway B (moderate suspicion, ultrasound available): Perform fasting bile acids first. If elevated, proceed to postprandial bile acids and ultrasound. This pathway reduces unnecessary testing in cats with low pretest probability.
• Pathway C (low suspicion or limited resources): Perform fasting bile acids and serum ammonia. If either is elevated, refer for ultrasound or CT angiography. This pathway is appropriate when ultrasound is not available in-house.

Document the chosen pathway and the rationale in the medical record. The review "Congenital Portosystemic Shunts in Dogs and Cats: Classification, Pathophysiology, Clinical Presentation and Diagnosis" (Veterinary sciences, 2023, PubMed ID 36851464) provides context for diagnostic decision-making.

Medical Management Decision Framework

For cats diagnosed with PSS, the first decision is whether to pursue medical management alone or as a bridge to surgery. This decision depends on the cat's clinical status, owner preferences, and available surgical resources.

Medical Management Initiation Criteria

Initiate medical management in the following situations:

• Preoperative stabilization: All cats scheduled for surgery should receive medical management for 2 to 4 weeks before surgery to reduce the risk of complications.
• Surgical contraindications: Cats with severe comorbidities, advanced age, or inaccessible shunts may be managed medically long-term.
• Owner declination: Owners who decline surgery should be offered medical management as a palliative option.
• Financial constraints: When surgical costs are prohibitive, medical management provides a more affordable alternative.

Document the reason for choosing medical management and the specific treatment plan. Include the target stool frequency for lactulose titration, the antibiotic chosen and duration, and the dietary plan.

Medical Management Monitoring Protocol

Establish a monitoring schedule for cats on medical management:

• Week 1: Recheck at 7 days to assess clinical response, stool frequency, and appetite. Adjust lactulose dose if needed. Measure body weight and body condition score.
• Month 1: Recheck at 30 days with repeat bile acids or ammonia. Assess neurologic status and quality of life. Adjust diet if weight loss or gain is excessive.
• Every 3 months: Recheck for stable cats. Monitor body weight, stool frequency, and neurologic status. Repeat bile acids every 6 to 12 months.
• Emergency recheck: Any recurrence of neurologic signs, seizures, or vomiting should prompt immediate re-evaluation.

Record all monitoring data in a standardized format. The World Organisation for Animal Health provides general guidance on animal welfare assessment that can be adapted for PSS cases (Animal Health and Welfare, WOAH, www.woah.org/en/what-we-do/animal-health-and-welfare).

Medical Management Failure Criteria

Identify medical management failure using the following criteria:

• Persistent neurologic signs: Any neurologic signs that do not resolve within 2 weeks of optimal medical therapy indicate failure.
• Recurrent hepatic encephalopathy: More than one episode of hepatic encephalopathy per month despite compliance with treatment.
• Progressive weight loss: Loss of more than 5% body weight over 3 months despite adequate caloric intake.
• Poor quality of life: Owner reports decreased activity, reduced interaction, or frequent illness.
• Rising bile acids or ammonia: Serial measurements showing increasing values despite stable medical therapy.

When any of these criteria are met, escalate to surgical consultation. Document the failure criteria met and the discussion with the owner about surgical options.

Surgical Decision Framework

For cats that are surgical candidates, the decision framework guides technique selection and perioperative management.

Surgical Technique Selection Criteria

Select the surgical technique based on shunt type, location, and available expertise:

• Extrahepatic shunt, accessible: Ameroid constrictor or cellophane banding are preferred for gradual occlusion. Suture ligation may be considered if the shunt is small and easily accessible, but carries higher risk of portal hypertension.
• Extrahepatic shunt, difficult access: Cellophane banding may be easier to place than an ameroid constrictor in tight surgical fields. Refer to a specialist if the surgeon is not comfortable with the approach.
• Intrahepatic shunt: Refer to a specialty center with experience in intrahepatic shunt management. Options include ameroid constrictor, cellophane banding, or advanced techniques such as thrombogenic coil embolization. The article "Intrahepatic Congenital Portosystemic Shunts" (The Veterinary clinics of North America. Small animal practice, 2025, PubMed ID 40274472) provides detailed guidance.
• Multiple shunts: Each shunt should be identified and attenuated if possible. Complete attenuation of all shunts may not be achievable, and some cats may require continued medical management.

Document the technique chosen and the rationale. Record intraoperative portal pressures if measured, as this guides the degree of attenuation.

Perioperative Monitoring Protocol

Establish a standardized perioperative monitoring protocol:

• Preoperative: Document baseline bile acids, ammonia, CBC, biochemistry, and urinalysis. Assess hydration and electrolyte status. Administer lactulose and antibiotics as prescribed. Fast for 8 to 12 hours before surgery.
• Intraoperative: Monitor portal pressures before and after attenuation. Record the degree of attenuation achieved. Document any complications such as hemorrhage or hypotension.
• Postoperative day 1: Monitor body weight, hydration status, mentation, and appetite every 4 hours. Check blood glucose every 6 hours. Assess for signs of portal hypertension: abdominal pain, vomiting, diarrhea, or ascites.
• Postoperative days 2 to 4: Continue monitoring every 8 hours. Gradually reintroduce food. Administer lactulose and antibiotics as prescribed. Discharge when the cat is eating, hydrated, and neurologically stable.
• Postoperative week 2: Recheck for suture removal if applicable. Assess neurologic status and appetite. Repeat bile acids if clinically indicated.
• Postoperative months 1, 3, and 6: Recheck with bile acids and clinical assessment. Annual rechecks thereafter.

Record all monitoring data in a standardized format. The review "Congenital Portosystemic Shunts in Dogs and Cats: Treatment, Complications and Prognosis" (Veterinary sciences, 2023, PubMed ID 37235429) provides outcome data that can guide monitoring frequency.

Surgical Complication Management

Develop a plan for managing common surgical complications:

• Acute portal hypertension: Signs include abdominal pain, vomiting, diarrhea, and ascites within 24 to 48 hours of surgery. Management includes intravenous fluid resuscitation, pain management, and possible surgical revision to reduce the degree of attenuation. Immediate referral to a specialist is indicated if the clinician is not comfortable with revision surgery.
• Seizures: Postoperative seizures may indicate persistent hepatic encephalopathy or hypoglycemia. Check blood glucose immediately. Administer anticonvulsants such as levetiracetam if seizures persist. Evaluate for other causes such as electrolyte imbalances or intracranial disease.
• Hypoglycemia: Check blood glucose every 6 hours for the first 24 hours. Administer dextrose supplementation if glucose is below 60 mg/dL. Adjust intravenous fluids accordingly.
• Pancreatitis: Signs include vomiting, abdominal pain, and anorexia. Management includes intravenous fluids, pain management, and antiemetics. Monitor pancreatic lipase immunoreactivity if available.
• Hemorrhage: Monitor for signs of internal bleeding such as pale mucous membranes, tachycardia, or hypotension. Administer blood products if needed. Surgical exploration may be required for uncontrolled hemorrhage.

Document any complications and their management in the medical record. Communicate clearly with the owner about the complication and the expected outcome.

Troubleshooting Common Clinical Scenarios

This section provides step-by-step troubleshooting for common clinical scenarios encountered in PSS management.

Scenario 1: Cat with Normal Bile Acids but High Clinical Suspicion

Some cats with PSS may have normal bile acids, particularly if the shunt is small or if the cat is on medical therapy. The study "Ultrasonographic diagnosis of portosystemic shunting in dogs and cats" (Veterinary radiology & ultrasound, 2004, PubMed ID 15487568) describes limitations of ultrasound that may also apply to bile acid testing.

Troubleshooting steps:

1. Repeat bile acids after a high-protein meal challenge. Feed a meal of canned cat food and collect a postprandial sample at 2 hours.
2. Measure serum ammonia. Sample handling is critical: use a heparinized tube, place on ice, and process within 30 minutes.
3. Perform abdominal ultrasound with a focus on the portal vasculature. Consider referral to a radiologist with experience in PSS diagnosis.
4. If ultrasound is negative but suspicion remains, proceed to CT angiography. This is the gold standard for shunt detection.
5. Consider other causes of clinical signs, such as primary epilepsy, toxin exposure, or other metabolic diseases.

Document each step and the results. If all tests are negative but clinical signs persist, consider referral to an internist for further evaluation.

Scenario 2: Cat with Poor Response to Medical Management

Some cats do not improve adequately with medical management. The first step is to assess compliance and dosing.

Troubleshooting steps:

1. Review the treatment plan with the owner. Confirm that lactulose is being administered at the correct dose and frequency. Ask about stool frequency and consistency.
2. Check that the cat is eating the prescribed diet. Some cats refuse hepatic support diets. Offer alternative low-protein options or consult with a veterinary nutritionist.
3. Assess for concurrent conditions that may worsen hepatic encephalopathy, such as constipation, gastrointestinal bleeding, or infection.
4. Consider adding or changing antibiotics. If the cat is on neomycin, consider switching to metronidazole or adding it as combination therapy.
5. Measure bile acids or ammonia to assess biochemical response. If values remain elevated despite optimal therapy, consider surgical consultation.
6. Evaluate for progressive liver disease or other hepatobiliary conditions. The retrospective study of biochemical profile changes in cats with different hepatobiliary diseases (Journal of feline medicine and surgery, 2025, PubMed ID 40470580) provides context for interpreting laboratory abnormalities.

Document each troubleshooting step and the outcome. If the cat does not improve after these interventions, escalate to surgical consultation.

Scenario 3: Cat with Postoperative Neurologic Deterioration

Some cats may experience worsening neurologic signs after surgery. This requires urgent evaluation.

Troubleshooting steps:

1. Check blood glucose immediately. Hypoglycemia is a common cause of postoperative neurologic signs.
2. Assess for portal hypertension. Check for abdominal pain, vomiting, diarrhea, or ascites. Measure portal pressure if a catheter is in place.
3. Evaluate for seizures. If the cat is seizing, administer anticonvulsants such as levetiracetam. Check for other causes such as electrolyte imbalances or intracranial disease.
4. Review the surgical record. Determine the degree of attenuation achieved and whether portal pressures were measured.
5. Consider the possibility of incomplete shunt closure or multiple shunts. If neurologic signs persist, repeat bile acids or ammonia to assess shunt function.
6. If signs are severe or progressive, refer to a specialist for further evaluation and management.

Document all findings and interventions. Communicate clearly with the owner about the situation and the plan.

Scenario 4: Cat with Recurrent Struvite Urolithiasis

Cats with PSS are predisposed to urate urolithiasis, but struvite stones can also occur. Recurrent urolithiasis requires evaluation of the underlying cause.

Troubleshooting steps:

1. Perform urinalysis with sediment examination. Look for ammonium biurate crystals, which are specific for PSS.
2. Measure urine pH. Struvite stones form in alkaline urine, while urate stones form in acidic urine.
3. Consider dietary modification. If the cat is on a hepatic support diet, check the urine pH and adjust if needed. Some hepatic diets may promote struvite formation.
4. Evaluate for urinary tract infection. Perform urine culture and sensitivity if indicated.
5. Consider medical dissolution or surgical removal of stones. Urate stones may dissolve with medical management of PSS, but struvite stones may require dietary modification or surgery.
6. If urolithiasis recurs despite optimal management, consider surgical attenuation of the shunt to reduce urate excretion.

Document each troubleshooting step and the outcome. The Merck Veterinary Manual provides guidance on managing feline urolithiasis (Merck Veterinary Manual, www.merckvetmanual.com/).

Record System for PSS Cases

A standardized record system improves consistency and outcomes in PSS management. The following template can be adapted for clinical use.

Initial Diagnostic Record

Record the following data at the initial diagnostic visit:

• Signalment: Breed, age, sex, weight, body condition score
• Presenting signs: Neurologic, gastrointestinal, urinary, or other
• Duration of signs: Days, weeks, or months
• Triggering factors: High-protein meal, stress, or other
• Previous treatments: Medications, diets, or surgeries
• Physical examination findings: Mentation, neurologic status, body condition, abdominal palpation
• Laboratory results: Bile acids (fasting and postprandial), ammonia, CBC, biochemistry, urinalysis
• Imaging results: Ultrasound findings, shunt type and location, CT angiography if performed
• Diagnosis: PSS confirmed or suspected
• Treatment plan: Medical management, surgical referral, or both

Medical Management Record

Record the following data at each medical management visit:

• Date of visit
• Body weight and body condition score
• Neurologic status: Normal, mild signs, moderate signs, severe signs
• Stool frequency and consistency: Number of stools per day, consistency score (1 to 5)
• Lactulose dose: mL per dose, frequency, total daily dose
• Antibiotic dose: Drug name, dose, frequency
• Diet: Type, amount fed, appetite
• Bile acids or ammonia: Values if measured
• Quality of life assessment: Owner-reported activity, interaction, appetite
• Complications: Any adverse effects or intercurrent illness
• Plan: Continue current therapy, adjust doses, or escalate to surgery

Surgical Record

Record the following data for surgical cases:

• Preoperative data: Bile acids, ammonia, CBC, biochemistry, urinalysis, weight
• Surgical date and procedure: Shunt type, location, attenuation technique
• Intraoperative portal pressures: Before and after attenuation
• Degree of attenuation: Percentage occlusion achieved
• Complications: Hemorrhage, hypotension, or other
• Postoperative monitoring: Daily weight, hydration, mentation, appetite, glucose
• Discharge date and instructions: Medications, diet, activity restrictions
• Follow-up schedule: 2 weeks, 1 month, 3 months, 6 months, annually
• Long-term outcome: Bile acids at follow-up, clinical status, quality of life

Common Failure Patterns in Decision-Making

Recognizing common failure patterns helps clinicians avoid diagnostic and therapeutic errors.

Diagnostic Failure Patterns

• Failure to consider PSS in young cats with neurologic signs: Many clinicians attribute neurologic signs to idiopathic epilepsy or toxin exposure without considering PSS. Maintain a high index of suspicion in young cats, especially purebreds.
• Reliance on single diagnostic test: Bile acids can be normal in some cats with PSS. Use multiple tests including ammonia and imaging to confirm the diagnosis.
• Inadequate imaging: Ultrasound is operator-dependent and may miss small or atypically located shunts. Refer to a radiologist with experience in PSS diagnosis if initial imaging is negative.
• Failure to perform CT angiography: CT angiography provides the most accurate anatomic information for surgical planning. Do not rely solely on ultrasound for surgical decision-making.

Medical Management Failure Patterns

• Inadequate lactulose titration: Many clinicians underdose lactulose. Titrate to produce 2 to 3 soft stools per day. Document stool frequency at each visit.
• Inappropriate antibiotic selection: Neomycin and metronidazole are the most commonly used antibiotics. Avoid broad-spectrum antibiotics that may disrupt the intestinal microbiome. The diagnosis and interpretation of intestinal dysbiosis in dogs and cats (Veterinary Journal, 2016, Elsevier Scopus ID 10.1016/j.tvjl.2016.04.011) provides context for antibiotic selection.
• Failure to monitor for complications: Cats on long-term medical management can develop complications such as diarrhea, dehydration, or malnutrition. Monitor body weight, stool frequency, and appetite at each visit.
• Delayed surgical referral: Many cats are managed medically for too long before surgical referral. Use the failure criteria outlined above to determine when to escalate.

Surgical Failure Patterns

• Inadequate preoperative stabilization: Cats that are not medically stabilized before surgery have higher complication rates. Ensure that neurologic signs are controlled and hydration is normal before surgery.
• Overly aggressive attenuation: Suture ligation carries a higher risk of acute portal hypertension. Use gradual occlusion techniques such as ameroid constrictor or cellophane banding when possible.
• Failure to monitor for postoperative complications: Portal hypertension, seizures, and hypoglycemia can occur after surgery. Monitor closely for the first 48 hours and have a plan for managing complications.
• Incomplete shunt closure: Some shunts do not close completely after attenuation. Follow up with bile acids at 1, 3, and 6 months postoperatively to assess shunt function.

Professional Escalation Criteria

Clear escalation criteria ensure that cats receive appropriate specialist care when needed.

When to Refer to an Internist

Refer to a veterinary internist in the following situations:

• Diagnostic uncertainty: When bile acids, ammonia, and imaging are inconclusive but clinical suspicion remains high.
• Complex medical management: When cats do not respond to standard medical therapy or require multiple medications.
• Concurrent hepatobiliary disease: When other liver conditions such as cholangitis or hepatic lipidosis are suspected.
• Recurrent complications: When cats experience frequent episodes of hepatic encephalopathy despite optimal medical management.

When to Refer to a Surgeon

Refer to a veterinary surgeon in the following situations:

• Surgical candidate: Any cat with confirmed PSS that is a candidate for surgical attenuation.
• Intrahepatic shunt: Intrahepatic shunts require advanced surgical techniques and should be managed at a specialty center.
• Complex shunt anatomy: Multiple shunts, aberrant vessel location, or previous failed attenuation.
• Surgical complications: Portal hypertension, hemorrhage, or other complications that require revision surgery.

When to Refer to a Radiologist

Refer to a veterinary radiologist in the following situations:

• Inconclusive ultrasound: When ultrasound does not identify a shunt but clinical suspicion remains high.
• Preoperative planning: CT angiography provides detailed anatomy for surgical planning.
• Postoperative assessment: When bile acids remain elevated after surgery and shunt closure is uncertain.

Document all referrals and the reason for referral in the medical record. Communicate with the specialist to ensure continuity of care.

Frequently Asked Questions

What is the most common presenting sign of portosystemic shunt in cats?

Neurologic signs are the most common presenting complaint, including circling, head pressing, ataxia, and seizures. These signs are often intermittent and may be triggered by eating a high-protein meal. Gastrointestinal signs such as vomiting and diarrhea are also common. The Merck Veterinary Manual provides an overview of clinical signs in cats with PSS (Merck Veterinary Manual, www.merckvetmanual.com/).

How is a portosystemic shunt diagnosed in cats?

Diagnosis begins with screening tests such as fasting and postprandial serum bile acids or serum ammonia. Elevated results suggest portosystemic shunting. Abdominal ultrasound is used to identify the shunt vessel, and CT angiography provides detailed anatomy for surgical planning. A stepwise approach minimizes unnecessary testing while ensuring accurate diagnosis.

Can a portosystemic shunt be managed without surgery?

Yes, medical management is an option for cats that are not surgical candidates or when owners decline surgery. Treatment includes a low-protein diet, lactulose to reduce ammonia absorption, and antibiotics to decrease bacterial ammonia production. However, medical management is palliative and does not correct the underlying shunt. Most cats require lifelong therapy and may experience recurrent clinical signs.

What is the success rate of surgical attenuation in cats?

Surgical attenuation has a good to excellent success rate in cats, with most achieving resolution of clinical signs and improved quality of life. The specific success rate depends on shunt type, surgical technique, and surgeon experience. Gradual occlusion techniques such as cellophane banding and ameroid constrictors have favorable outcomes with lower complication rates.

What are the risks of surgery for portosystemic shunt?

The main risk is acute portal hypertension if the shunt is occluded too rapidly. Signs include abdominal pain, vomiting, diarrhea, and ascites. Other risks include hypoglycemia, seizures, pancreatitis, and anesthetic complications. These risks are minimized with careful preoperative stabilization, gradual attenuation techniques, and intraoperative monitoring.

How long does recovery take after shunt attenuation surgery?

Most cats are hospitalized for 2 to 4 days after surgery. Full recovery and return to normal activity typically takes 2 to 4 weeks. Neurologic signs often improve within days to weeks, though some cats may have residual deficits. Follow-up bile acid testing is recommended at 1, 3, and 6 months postoperatively to confirm shunt closure.

What dietary changes are needed for a cat with a portosystemic shunt?

Cats with PSS should be fed a low-protein, high-quality diet to reduce ammonia production. Commercial hepatic support diets are available and are formulated to meet the nutritional needs of cats while minimizing protein load. Protein restriction must be balanced against the risk of malnutrition, as cats are obligate carnivores. Gradual dietary transition is recommended to avoid anorexia.

When should a cat with a portosystemic shunt be referred to a specialist?

Referral is indicated if the clinician lacks experience with PSS surgery, if the shunt is intrahepatic or complex, or if complications arise during medical management. Cats with refractory seizures, progressive neurologic decline, or signs of portal hypertension after surgery should be referred immediately. Collaboration with a veterinary internist or surgeon improves outcomes for complex cases.

Related Veterinary Guides

• Cat
• Cat Urinary Tract Diet
• Clinical Biochemistry Urinalysis
• Hypertrophic Cardiomyopathy In Cats
• Prescription Medicine For Cats

References and Further Reading

• www.merckvetmanual.com
• catvets.com
• www.acvim.org
• Merck Veterinary Manual. Merck Veterinary Manual.
• Animal Health and Welfare. World Organisation for Animal Health.
• Congenital Portosystemic Shunts in Dogs and Cats: Classification, Pathophysiology, Clinical Presentation and Diagnosis.. Veterinary sciences, 2023.
• Congenital Portosystemic Shunts in Dogs and Cats: Treatment, Complications and Prognosis.. Veterinary sciences, 2023.
• Ultrasonographic diagnosis of portosystemic shunting in dogs and cats.. Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association, 2004.
• Feline portosystemic shunts.. Seminars in veterinary medicine and surgery (small animal), 1997.
• Retrospective study of biochemical profile changes in 93 cats with different hepatobiliary diseases.. Journal of feline medicine and surgery, 2025.
• Intrahepatic Congenital Portosystemic Shunts.. The Veterinary clinics of North America. Small animal practice, 2025.
• Feline hepatic disease.. Veterinary Clinics of North America Small Animal Practice, 1984.
• Diagnosis and interpretation of intestinal dysbiosis in dogs and cats. Veterinary Journal, 2016.

This article is educational and is not a substitute for veterinary diagnosis or treatment. Contact a veterinarian for advice about an individual animal.